HB1375 (2020) Detail

(New Title) relative to claims for medical monitoring.


HB 1375 - VERSION ADOPTED BY BOTH BODIES

 

06/29/2020   1568s

2020 SESSION

20-2698

01/08

 

HOUSE BILL 1375

 

AN ACT relative to claims for medical monitoring.

 

SPONSORS: Rep. Hunt, Ches. 11; Sen. French, Dist 7

 

COMMITTEE: Commerce and Consumer Affairs

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This bill establishes the elements of a claim for medical monitoring and the damages that may be awarded.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

06/29/2020   1568s 20-2698

01/08

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty

 

AN ACT relative to claims for medical monitoring.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  New Chapter; Claims for Medical Monitoring.  Amend RSA by inserting after chapter 125-S the following new chapter:

CHAPTER 125-T

CLAIMS FOR MEDICAL MONITORING

125-T:1  Purpose.  The general court finds that a claim for medical monitoring is consistent with currently existing common law in the state of New Hampshire and other jurisdictions.  The purpose of this chapter is to make the remedy of medical monitoring damages more uniform and better address the needs of those exposed.

125-T:2  Definitions.  In this chapter:

I.  "Exposure" means ingestion, inhalation, contact with skin or eyes, or any other physical contact.

II.  "Hazardous or toxic substance" means any chemical or biological substance that is categorized as toxic, or an equivalent, by the United States Environmental Protection Agency (EPA) or the Agency for Toxic Substance and Disease Registry (ATSDR) of the United States Department of Health and Human Services.  Chemical or biological substances which are not so categorized may be proven to be hazardous or toxic by a preponderance of the evidence by expert testimony.

125-T:3  Elements of Claim.  

I.  In order to prove a claim for medical monitoring damages, the plaintiff must show by a preponderance of the evidence for each of the following that:

(a)  The defendant negligently caused significant exposure to a proven hazardous or toxic substance;

(b)  The plaintiff now suffers from an increased risk of illness, disease, or latent disease.  The plaintiff does not need to prove that the illness, disease, or latent disease is certain or likely to develop as a result of the exposure;

(c)  The increased risk under subparagraph (b) makes the need for diagnostic testing reasonably necessary; and

(d)  Medical tests exist to detect the illness, disease, or latent disease.

II.  A claim for medical monitoring damages may be made without proof of present physical injury or symptoms.

III.  Present or past health status shall not be at issue in a claim for medical monitoring.

125-T:4  Damages.

I.  Damages shall be limited to reasonably necessary periodic examinations and related costs.  The costs and necessity of such examinations shall be proven by expert testimony.

II.  If medical monitoring relief is awarded, a court may place the award into a court-supervised program administered by one or more medical professionals.

III.  Upon an award of medical monitoring damages, the court may award to the plaintiff reasonable attorney's fees and other litigation costs reasonably incurred.

125-T:5  Statute of Limitation.  Medical monitoring claims shall be made with 3 years of the effective date of this chapter or discovery of exposure.  The date when the hazardous or toxic substance was released is immaterial for purposes of this section.

125-T:6  Severability.  If any provision of this chapter or the application thereof to any person or circumstances is held invalid, such invalidity shall not affect other provisions or applications of the chapter which can be given effect without the invalid provision or application, and to this end the provisions of this chapter are declared to be severable.

2  Effective Date.  This act shall take effect upon its passage.

Links

HB1375 at GenCourtMobile
HB1375 Discussion

Action Dates

Date Body Type
Jan. 16, 2020 House Hearing
Feb. 4, 2020 House Exec Session
House Floor Vote
Feb. 19, 2020 House Floor Vote
June 24, 2020 Senate Hearing
June 24, 2020 Senate Hearing
Senate Hearing
June 29, 2020 Senate Floor Vote

Bill Text Revisions

HB1375 Revision: 8504 Date: June 30, 2020, 11:07 a.m.
HB1375 Revision: 8481 Date: June 29, 2020, 3:10 p.m.
HB1375 Revision: 7043 Date: Dec. 2, 2019, 3:27 p.m.

Docket

Date Status
Jan. 8, 2020 Introduced 01/08/2020 and referred to Commerce and Consumer Affairs HJ 1 P. 20
Jan. 16, 2020 Public Hearing: 01/16/2020 09:00 am LOB 302
Feb. 3, 2020 Subcommittee Work Session: 02/03/2020 01:00 pm LOB 302
Feb. 4, 2020 Executive Session: 02/04/2020 10:00 am LOB 302
Feb. 19, 2020 Committee Report: Ought to Pass for 02/19/2020 (Vote 19-1; CC) HC 7 P. 3
Committee Report: Ought to Pass (Vote 19-1; CC)
Feb. 19, 2020 Ought to Pass: MA VV 02/19/2020 HJ 4 P. 3
March 11, 2020 Introduced 03/11/2020 and Referred to Commerce; SJ 7
June 16, 2020 HB 1375 is vacated from Commerce and referred to Judiciary; (In recess 06/16/2020); SJ 9
June 24, 2020 Remote Hearing: 06/24/2020, 08:00 am; SC 24
June 24, 2020 Remote Hearing: 06/24/2020, 08:05 am, on proposed amendment # 2020-1548s; SC 24
Committee members will receive secure Zoom invitations via email. SC 24
Members of the public may attend using the following links: SC 24
1. To sign-in and/or speak in support or opposition, please register in advance by using this link: https://www.zoom.us/webinar/register/WN_QH1esiFMQNC5q9CjM5O_jA SC 24
2. To submit your testimony to the committee, please send all documents via email to remotesenate@leg.state.nh.us SC 24
3. To listen via telephone: Dial (for higher quality, dial a number based on your current location): 1-301-715-8592, or 1-312-626-6799, or 1-929-205-6099, or 1-253-215-8782, or 1-346-248-7799, or 1-669-900-6833 SC 24
4. Or iPhone one-tap: 13126266799,,94954573376# or 19292056099,,94954573376# SC 24
5. Webinar ID: 949 5457 3376 SC 24
6. To view/listen to this hearing on YouTube, use this link: https://www.youtube.com/channel/UCjBZdtrjRnQdmg-2MPMiWrA SC 24
The following email will be monitored throughout the meeting by someone who can assist with and alert the committee to any technical issues: remotesenate@leg.state.nh.us or call (603-271-3043). SC 24
The following email will be monitored throughout the meeting by someone who can assist with and alert the committee to any technical issues: remotesenate@leg.state.nh.us or call (603-271-3043). SC 24
June 29, 2020 Committee Report: Ought to Pass with Amendment # 2020-1568s, 06/29/2020; SC 25
June 29, 2020 Committee Amendment # 2020-1568s, RC 14Y-10N, AA; 06/29/2020; SJ 9
June 29, 2020 Ought to Pass with Amendment 2020-1568s, MA, VV; OT3rdg; 06/29/2020; SJ 9
House Concurs with Senate Amendment MA RC (227-105) 06/30/2020
June 30, 2020 House Concurs with Senate Amendment (Rep. Butler): MA RC 227-105 06/30/2020
June 29, 2020 Enrolled (In recess 06/29/2020); SJ 9
Enrolled 06/30/2020 HJ 10